MIR145 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 155230825 (-)-epigallocatechin 3-gallate inhibits the reaction [angiotensin II decreases expression of MIR145a RNA in vascular smooth more ... RGD MIR145 Human 1,2-dichloroethane decreases expression ISO Mir145a (Mus musculus) 6480464 ethylene dichloride results in decreased expression of MIR145A mRNA CTD PMID:28960355 MIR145 Human 1,3,5-trinitro-1,3,5-triazinane decreases expression ISO Mir145a (Mus musculus) 6480464 cyclonite results in decreased expression of MIR145 mRNA CTD PMID:19270793 MIR145 Human 1,4-dichlorobenzene decreases expression ISO Mir145a (Mus musculus) 6480464 4-dichlorobenzene results in decreased expression of MIR145A mRNA CTD PMID:32105654 MIR145 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MIR145 mRNA CTD PMID:30328349 MIR145 Human 3-methylcholanthrene decreases expression ISO Mir145a (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of MIR145A mRNA CTD PMID:25926378 MIR145 Human 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 IL6 protein inhibits the reaction [Decitabine results in increased expression of MIR145 mRNA] CTD PMID:17621267 MIR145 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of MIR145 mRNA CTD PMID:17621267 MIR145 Human aflatoxin B1 decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Aflatoxin B1 results in decreased expression of MIR145 mRNA CTD PMID:24472605 MIR145 Human aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of MIR145 mRNA CTD PMID:24223694 MIR145 Human all-trans-retinoic acid multiple interactions EXP 6480464 [sodium arsenite co-treated with Tretinoin] results in increased expression of MIR145; [Tretinoin co-treated with Phenylbutyrates more ... CTD PMID:23284745|PMID:39571964 MIR145 Human angiotensin II decreases expression EXP 155230825 angiotensin II decreases expression of MIR145a RNA in vascular smooth muscle cell RGD MIR145 Human angiotensin II decreases expression ISO Mir145a (Mus musculus) 155260287 Angiotensin II decreases expression of miRNA145 RNA in vascular smooth muscle cells RGD MIR145 Human antigen decreases expression ISO Mir145a (Mus musculus) 6480464 Antigens results in decreased expression of MIR145A mRNA CTD PMID:27038180 MIR145 Human arecoline increases expression EXP 6480464 Arecoline results in increased expression of MIR145 CTD PMID:21750350 MIR145 Human arsane increases expression ISO Mir145a (Mus musculus) 6480464 Arsenic results in increased expression of MIR145A mRNA CTD PMID:36463740 MIR145 Human arsenic atom increases expression ISO Mir145a (Mus musculus) 6480464 Arsenic results in increased expression of MIR145A mRNA CTD PMID:36463740 MIR145 Human arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of MIR145 mRNA CTD PMID:22728250 MIR145 Human atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of MIR145 mRNA CTD PMID:29630879 MIR145 Human atrazine decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of MIR145 mRNA CTD PMID:31185338 MIR145 Human bis(2-chloroethyl) sulfide decreases expression ISO Mir145a (Mus musculus) 6480464 Mustard Gas results in decreased expression of MIR145A mRNA CTD PMID:26456178 MIR145 Human bis(2-ethylhexyl) phthalate decreases expression ISO Mir145a (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of MIR145A CTD PMID:32642447 MIR145 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MIR145 CTD PMID:33229049 MIR145 Human bisphenol A decreases expression ISO Mir145a (Mus musculus) 6480464 bisphenol A results in decreased expression of MIR145A mRNA CTD PMID:32156529 MIR145 Human bleomycin A2 decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Bleomycin results in decreased expression of MIR145 mRNA CTD PMID:25933445 MIR145 Human bucladesine decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Bucladesine results in decreased expression of MIR145 mRNA CTD PMID:23045399 MIR145 Human bucladesine decreases expression ISO Mir145a (Mus musculus) 6480464 Bucladesine results in decreased expression of MIR145 mRNA CTD PMID:23045399 MIR145 Human buta-1,3-diene decreases expression ISO Mir145a (Mus musculus) 6480464 1,3-butadiene results in decreased expression of MIR145 mRNA CTD PMID:29038090 MIR145 Human cadmium dichloride increases expression ISO Mir145a (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MIR145A mRNA CTD PMID:35183672 MIR145 Human camptothecin increases expression EXP 6480464 Camptothecin results in increased expression of MIR145 mRNA CTD PMID:24726431 MIR145 Human camptothecin decreases expression EXP 6480464 Camptothecin results in decreased expression of MIR145 mRNA CTD PMID:24726431 MIR145 Human cannabidiol multiple interactions ISO Mir145a (Mus musculus) 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of MIR145A mRNA CTD PMID:30742662 MIR145 Human carbon nanotube decreases expression ISO Mir145a (Mus musculus) 6480464 Nanotubes, Carbon results in decreased expression of MIR145A mRNA CTD PMID:25926378 MIR145 Human cisplatin increases expression ISO Mir145 (Rattus norvegicus) 6480464 Cisplatin results in increased expression of MIR145 mRNA CTD PMID:24880025 MIR145 Human cisplatin decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Cisplatin results in decreased expression of MIR145 mRNA CTD PMID:27397436 MIR145 Human copper atom increases expression ISO Mir145 (Rattus norvegicus) 6480464 Copper results in increased expression of MIR145 mRNA CTD PMID:30556269 MIR145 Human copper(0) increases expression ISO Mir145 (Rattus norvegicus) 6480464 Copper results in increased expression of MIR145 mRNA CTD PMID:30556269 MIR145 Human D-glucose increases expression EXP 6480464 Glucose results in increased expression of MIR145 mRNA CTD PMID:24223694 MIR145 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of MIR145 mRNA CTD PMID:26206603 MIR145 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of MIR145 mRNA CTD PMID:23430952 MIR145 Human dimethylarsinic acid multiple interactions ISO Mir145a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 MIR145 Human ethanol decreases expression ISO Mir145a (Mus musculus) 6480464 Ethanol results in decreased expression of MIR145A mRNA CTD PMID:28285099 MIR145 Human ethanol increases expression ISO Mir145a (Mus musculus) 6480464 Ethanol results in increased expression of MIR145A mRNA CTD PMID:19091803 MIR145 Human ethanol multiple interactions ISO Mir145a (Mus musculus) 6480464 Carbon Tetrachloride inhibits the reaction [Ethanol results in decreased expression of MIR145A mRNA] CTD PMID:28285099 MIR145 Human furan decreases expression ISO Mir145a (Mus musculus) 6480464 furan results in decreased expression of MIR145A mRNA CTD PMID:37517673 MIR145 Human glucose increases expression EXP 6480464 Glucose results in increased expression of MIR145 mRNA CTD PMID:24223694 MIR145 Human hexanal decreases expression ISO Mir145 (Rattus norvegicus) 6480464 n-hexanal results in decreased expression of MIR145 mRNA CTD PMID:26403475 MIR145 Human isoprenaline increases expression ISO Mir145a (Mus musculus) 155260312 isoprenaline increases expression of miRNA145 RNA in left ventricular myocardial tissues RGD MIR145 Human mechlorethamine increases expression ISO Mir145 (Rattus norvegicus) 6480464 Mechlorethamine results in increased expression of MIR145 mRNA CTD PMID:33971176 MIR145 Human methylarsonic acid multiple interactions ISO Mir145a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 MIR145 Human N(6)-methyladenosine multiple interactions EXP 6480464 [MIR145 mRNA results in decreased expression of YTHDF2 protein] which results in increased abundance of more ... CTD PMID:28104805 MIR145 Human N(6)-methyladenosine increases abundance EXP 6480464 MIR145 mRNA results in increased abundance of N-methyladenosine CTD PMID:28104805 MIR145 Human nitrofen increases expression ISO Mir145 (Rattus norvegicus) 6480464 nitrofen results in increased expression of MIR145 mRNA CTD PMID:26720608 MIR145 Human omethoate affects response to substance EXP 6480464 MIR145 gene SNP affects the susceptibility to dimethoxon CTD PMID:30684755 MIR145 Human ozone increases expression EXP 6480464 Ozone results in increased expression of MIR145 mRNA CTD PMID:24771714 MIR145 Human ozone increases expression ISO Mir145a (Mus musculus) 6480464 Ozone results in increased expression of MIR145A CTD PMID:35201360 MIR145 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MIR145 mRNA CTD PMID:25314302 MIR145 Human perfluorooctane-1-sulfonic acid increases expression ISO Mir145a (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of MIR145 mRNA CTD PMID:24098361 MIR145 Human perfluorooctane-1-sulfonic acid decreases expression ISO Mir145a (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of MIR145 mRNA CTD PMID:25510869 MIR145 Human phenol decreases expression ISO Mir145a (Mus musculus) 6480464 Phenol results in decreased expression of MIR145A mRNA CTD PMID:32105654 MIR145 Human potassium dichromate decreases expression ISO Mir145a (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of MIR145 mRNA CTD PMID:23608068 MIR145 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MIR145 mRNA CTD PMID:30328349 MIR145 Human pyrethrins decreases expression ISO Mir145a (Mus musculus) 6480464 Pyrethrins results in decreased expression of MIR145A CTD PMID:35276145 MIR145 Human quartz decreases expression ISO Mir145 (Rattus norvegicus) 6480464 Quartz results in decreased expression of MIR145 mRNA CTD PMID:23208435 MIR145 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MIR145 mRNA CTD PMID:22016468|PMID:23954321 MIR145 Human rifampicin increases expression EXP 6480464 Rifampin results in increased expression of MIR145 mRNA CTD PMID:24552687 MIR145 Human SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of MIR145] CTD PMID:21712382 MIR145 Human sodium arsenate multiple interactions ISO Mir145a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 MIR145 Human sodium arsenite decreases expression ISO Mir145a (Mus musculus) 6480464 sodium arsenite results in decreased expression of MIR145A mRNA CTD PMID:24896083 MIR145 Human sodium arsenite multiple interactions ISO Mir145a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 MIR145 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MIR145 mRNA CTD PMID:28972549 MIR145 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MIR145 mRNA CTD PMID:29705342 MIR145 Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite co-treated with Tretinoin] results in increased expression of MIR145; MIR145 mRNA promotes the more ... CTD PMID:29705342|PMID:39571964 MIR145 Human tetrachloromethane multiple interactions ISO Mir145a (Mus musculus) 6480464 Carbon Tetrachloride inhibits the reaction [Ethanol results in decreased expression of MIR145A mRNA] CTD PMID:28285099 MIR145 Human trichostatin A increases expression ISO Mir145a (Mus musculus) 6480464 trichostatin A results in increased expression of MIR145 mRNA CTD PMID:24896083 MIR145 Human urethane decreases expression ISO Mir145a (Mus musculus) 6480464 Urethane results in decreased expression of MIR145 mRNA CTD PMID:23761296 MIR145 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MIR145 mRNA CTD PMID:29154799 MIR145 Human valproic acid increases expression ISO Mir145a (Mus musculus) 6480464 Valproic Acid results in increased expression of MIR145A mRNA CTD PMID:24896083 MIR145 Human vinclozolin decreases expression ISO Mir145 (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of MIR145 mRNA CTD PMID:23034163 MIR145 Human zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of MIR145 mRNA CTD PMID:22171008 MIR145 Human zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of MIR145 mRNA] CTD PMID:22171008 MIR145 Human zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of MIR145 mRNA CTD PMID:22171008 MIR145 Human zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of MIR145 mRNA] CTD PMID:22171008
